VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Markman on Important Factors of BSO in Ovarian Cancer

Maurie Markman, MD
Published: Monday, Oct 03, 2016


Maurie Markman, MD, president, Medicine and Science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, discusses the most important factors of bilateral salpingo-oophorectomy (BSO) to discuss with patients with ovarian cancer.

First, the outcome of the surgery cannot be guaranteed, but the procedure is designed to eliminate 80% risk for disease, Markman explains. However, one challenge lies with the fact that the peritoneal lining is made up of the same cells that line the ovaries. Additional environmental exposures, which are still unknown, may still prove to be a risk for developing ovarian cancer.

Secondly, surgical menopause is a concern to discuss with patients. This places physiological effects of estrogen on the heart and bones, as well as psychosocial effects on the patient, he adds.

Maurie Markman, MD, president, Medicine and Science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, discusses the most important factors of bilateral salpingo-oophorectomy (BSO) to discuss with patients with ovarian cancer.

First, the outcome of the surgery cannot be guaranteed, but the procedure is designed to eliminate 80% risk for disease, Markman explains. However, one challenge lies with the fact that the peritoneal lining is made up of the same cells that line the ovaries. Additional environmental exposures, which are still unknown, may still prove to be a risk for developing ovarian cancer.

Secondly, surgical menopause is a concern to discuss with patients. This places physiological effects of estrogen on the heart and bones, as well as psychosocial effects on the patient, he adds.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Expert Perspectives to Incorporate Evidence on PARP Inhibitors into Practice and Optimize the Medical Management of Ovarian CancerOct 31, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x